학술논문
Unfolding the role of the PI3K/AKT/MTOR pathway in male breast cancer: A pragmatic appraisal
Document Type
article
Source
Breast, Vol 72, Iss , Pp 103576- (2023)
Subject
Language
English
ISSN
1532-3080
Abstract
Breast cancer in men is rare, but a relevant public health issue, yielding a 25% higher risk of mortality comparing to female counterparts. The representation of males in clinical trials has been scarce and treatment decisions are based mainly on extrapolations from data in females. In the setting of estrogen-dependent metastatic disease, the use of everolimus has been seldom reported, although the PI3K/AKT/mTOR pathway seems to be a critical oncogenic driver. This paper dissects hallmark biological features of ER+/HER2-advanced male breast cancer, setting a comprehensive basis to promote personalized care, focusing on the potential of targeting the PI3K/AKT/mTOR pathway.